Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Huasheng Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company focuses primarily on cardiovascular, antiviral, and metabolic therapeutic areas, with a strong portfolio of generic medications including sartans and statins. Huasheng operates high-standard GMP manufacturing facilities and serves both domestic and international markets through its supply of high-quality chemical drugs. Its business model encompasses the entire value chain from chemical synthesis to final product commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Huasheng Biopharmaceutical.